Table 2.
Treatment responses after 3 months of treatment among evaluable patients.
| Variables | Total (n = 333) |
no LSMM (n = 212) |
LSMM (n = 121) |
p Value |
|---|---|---|---|---|
| Overall response | 0.007 | |||
| Complete response | 26 (7.8%) | 18 (8.5%) | 8 (6.6%) | |
| Partial response | 121 (36.3%) | 85 (40.1%) | 36 (29.8%) | |
| Stable disease | 106 (31.8%) | 71 (33.5%) | 35 (28.9%) | |
| Progressive disease | 80 (24.0%) | 38 (17.9%) | 42 (34.7%) | |
| Objective response | 147 (44.1%) | 103 (48.6%) | 44 (36.4%) | 0.031 |
| Disease control rate | 253 (76.0%) | 174 (82.1%) | 79 (65.3%) | <0.001 |
Data are n (%). LSMM, low skeletal muscle mass.